Illinois Prescription Monitoring Program Advisory Committee (ILPMPAC)

Section 2080.320  Illinois Prescription Monitoring Program Advisory Committee (ILPMPAC) The Illinois Prescription Monitoring Program Advisory Committee (ILPMPAC) is established to aid in the implementation of the ILPMP and to advise the Clinical Director on the professional performance of prescribers and dispensers and other matters relevant to the ILPMPAC's field of competence. [720 ILCS 570/320(a)] a)         The Clinical Director shall serve as a non-voting secretary of the committee and appoint the members of the ILPMPAC based on nominations from their respective professional associations.  The ILPMPAC may appoint a chairperson and other officers as it deems appropriate . [720 ILCS 570/320(b)] b)         Pursuant to 720 ILCS 570/320(b), the ILPMPAC shall consist of the following: 1)         one family or primary care physician; 2)         one pain specialist physician; 3)         four other physicians licensed to practice medicine in all of its branches, one of whom may be an ophthalmologist; 4)         three pharmacists; 5)         two advanced practice registered nurses; 6)         one dentist; 7)         one optometrist; 8)         one clinical representative from a statewide organization representing hospitals; and 9)         one physician assistant. c)         Pursuant to 720 ILCS 570/320(e), the ILPMPAC shall: 1)         evaluate and recommend changes to the Illinois Controlled Substances Act [720 ILCS 570]; 2)         evaluate and recommend changes to the Administrative Rules regarding the ILPMP; 3)         recommend inclusion of training materials for prescribers and dispensers regarding Continuing Medical Education and Continuing Education programs; 4)         at least on a semi-annual basis, review the contents of the ILPMP website (ilpmp.org) to ensure that the contents are current; 5)         at least on a semi-annual basis, review opportunities for federal grants and other forms of funding to support projects to increase the number of EHRs integrating seamlessly to the ILPMP; and 6)         at least on a semi-annual basis, review and prepare any communication to be sent to all registered users of the system relevant to prescribing and dispensing of controlled substances.